Medications for Metabolic Diseases
5 results
Bioferr 90 (dual-iron)
(Dual-Iron)Biocon Pharma Inc.
Usage: BioFerr™ 90 is indicated for treating all anemias responsive to oral iron therapy, including hypochromic anemia related to pregnancy, blood loss (acute or chronic), metabolic diseases, post-surgical recovery, and dietary deficiencies.
Cystadane (betaine)
(betaine)Rare Disease Therapeutics, Inc.
Usage: Cystadane® (betaine anhydrous) is indicated for treating homocystinuria to reduce elevated homocysteine levels. It is used for conditions including cystathionine beta-synthase deficiency, 5,10-methylenetetrahydrofolate reductase deficiency, and cobalamin cofactor metabolism defects.
Fludeoxyglucose f 18 (fludeoxyglucose f 18 injection)
(Fludeoxyglucose F 18 Injection)Northland Nuclear Medicine
Usage: Fludeoxyglucose F 18 Injection is indicated for PET imaging to identify abnormal glucose metabolism in epilepsy, assess malignancy in cancer patients, and evaluate coronary artery disease with left ventricular dysfunction alongside myocardial perfusion imaging. It is not suitable for differentiating epileptogenic foci from other brain lesions.
Fludeoxyglucose f 18 (fludeoxyglucose f-18)
(Fludeoxyglucose F-18)Mayo Clinic
Usage: Fludeoxyglucose F 18 Injection USP is indicated for PET imaging to evaluate malignancy, assess glucose metabolism in coronary artery disease and left ventricular dysfunction, and identify abnormal glucose metabolism related to epileptic seizures.
Neonatal fe (iron, folic acid, cyanocobalamin, ascorbic acid)
(iron, folic acid, cyanocobalamin, ascorbic acid)SLV PHARMACEUTICALS LLC DBA AUM PHARMACEUTICALS
Usage: NEONATAL FE Rx Prenatal Vitamin with ferronyl iron is indicated for treating anemias responsive to oral iron therapy, including hypochromic anemia due to pregnancy, blood loss, metabolic disease, postsurgical recovery, and dietary deficiencies.